Breaking News Instant updates and real-time market news.

EVOK

Evoke Pharma

$2.63

0.03 (1.15%)

16:25
08/09/18
08/09
16:25
08/09/18
16:25

Evoke Pharma reports Q2 EPS (14c), consensus (17c)

CEO Dave Gonyer stated, "The June 1st submission of our 505(b)(2) New Drug Application (NDA) for Gimoti, our novel nasal delivery of metoclopramide for the treatment of symptoms associated with gastroparesis, represents another significant milestone for the Company and the opportunity to help women suffering from this debilitating disease. We anticipate receipt of the 74-Day FDA filing communication letter in mid-August and assignment of the Prescription Drug User Fee Act (PDUFA) goal date." Mr. Gonyer continued, "The recently granted patents in the European Union and Mexico expand our intellectual property portfolio and further validate our novel discovery of sex-based differences in the treatment of gastroparesis in women."

EVOK Evoke Pharma
$2.63

0.03 (1.15%)

10/19/17
10/19/17
INITIATION
Target $10

Buy
Evoke Pharma reinstated with a Buy at FBR Capital
FBR Capital analyst David Buck reinstated coverage of Evoke Pharma with a Buy rating and $10 price target.
10/06/17
GHSC
10/06/17
INITIATION
Target $10
GHSC
Buy
Evoke Pharma initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated Evoke Pharma with a Buy and $10 price target saying it has a clear regulatory path for advancing Gimoti as a metoclopramide nasal spray treatment for acute and recurrent gastroparesis in women with diabetes mellitus.

TODAY'S FREE FLY STORIES

SGMS

Scientific Games

$26.45

0.15 (0.57%)

16:34
09/25/18
09/25
16:34
09/25/18
16:34
Hot Stocks
Scientific Games signs contract with Hard Rock International »

Scientific Games…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGLY

Digital Ally

$3.75

-0.275 (-6.83%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Syndicate
Digital Ally files to sell common stock, no amount given »

Roth Capital Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

R

Ryder

$72.75

-0.04 (-0.05%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Ryder CFO Art Garcia to retire in April 2019 »

Ryder announced that Art…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BZH

Beazer Homes

$11.08

-0.015 (-0.14%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Beazer says Hurricane Florence will result in sales, closings shifting to FY19 »

Beazer Homes provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$172.88

-2.66 (-1.52%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Moody's appoints Mona Breed as CIO »

Moody's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 21

    Oct

FCFS

First Cash Financial

$83.03

0.625 (0.76%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
First Cash Financial announces move to Nasdaq from NYSE »

FirstCash announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

OKE

Oneok

$68.44

0.565 (0.83%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Oneok to construct additional NGL fractionation, pipeline capacity »

Oneok announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/25/18
09/25
16:30
09/25/18
16:30
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

MOR

MorphoSys

$27.13

0.315 (1.17%)

16:28
09/25/18
09/25
16:28
09/25/18
16:28
Hot Stocks
MorphoSys says licensee has begun study to test gselkumab in pediatric group »

MorphoSys announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:26
09/25/18
09/25
16:26
09/25/18
16:26
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Jefferies, Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:24
09/25/18
09/25
16:24
09/25/18
16:24
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:23
09/25/18
09/25
16:23
09/25/18
16:23
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem rises over 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell looks to bring mastitis treatment to market in 2020 »

ImmuCell announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell receives fourth complete letter of NADA for Nisin treatment for cows »

Immucell announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Verastem and CSPC Pharma sign license agreement to develop COPIKTRA in China »

Verastem and CSPC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

LOXO

Loxo Oncology

$166.80

3.73 (2.29%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Loxo Oncology announces LOXO-292 durability update »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Nov

  • 27

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
09/25/18
09/25
16:20
09/25/18
16:20
Options
Closing CBOE SPX and VIX Index summary for September 25th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

16:19
09/25/18
09/25
16:19
09/25/18
16:19
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike slips 4.1% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

16:19
09/25/18
09/25
16:19
09/25/18
16:19
Hot Stocks
Breaking Hot Stocks news story on KB Home »

KB Home rises over 4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TRN

Trinity Industries

$36.78

-0.37 (-1.00%)

16:19
09/25/18
09/25
16:19
09/25/18
16:19
Hot Stocks
Trinity Industries board approves separation of Arcosa »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASH

Meta Financial

$84.15

1.45 (1.75%)

16:18
09/25/18
09/25
16:18
09/25/18
16:18
Hot Stocks
Meta Financial anounces Brent Turner will step down as EVP »

Meta Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$212.99

1.81 (0.86%)

16:18
09/25/18
09/25
16:18
09/25/18
16:18
Earnings
Cintas raises FY19 EPS view to $7.19-$7.29 from $7.00-$7.15, consensus $7.16 »

Raises FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

16:18
09/25/18
09/25
16:18
09/25/18
16:18
Hot Stocks
Nike reports Q1 North America revenue $4.145B, up 6% »

Reports Q1 EMEA revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MRCY

Mercury Systems

$53.93

1.17 (2.22%)

16:17
09/25/18
09/25
16:17
09/25/18
16:17
Hot Stocks
Mercury Systems receives $5.5M order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/25/18
09/25
16:17
09/25/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.